Leserbrief
Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark
Digestive Diseases and Sciences · 21.08.2026
DOI: 10.1007/s10620-026-10189-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 21.08.2026. Verfasst von Matheus Souza. Beteiligte Einrichtung: Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. matheushenrique.gs@hotmail.com. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. matheushenrique.gs@hotmail.com.
ORCID-Profile: Matheus Souza
Zitieren
APA
Souza, M. (2026). Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10189-0
Vancouver
Souza M. Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10189-0
BibTeX
@article{Souza2026,
author = {Souza, Matheus},
title = {Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10189-0}
}
EUVIMED